scholarly journals Trends in International Cancer Research Investment 2006-2018

2021 ◽  
pp. 602-610
Author(s):  
Rachel Abudu ◽  
Gauthier Bouche ◽  
Karima Bourougaa ◽  
Lynne Davies ◽  
Kalina Duncan ◽  
...  
Keyword(s):  
Cancer Research ◽  
Early Detection ◽  
Cancer Biology ◽  
Research Funding ◽  
Cancer Site ◽  
Research Focus ◽  
Main Research ◽  
Diagnosis And Prognosis ◽  
Research Investment ◽  
And Control

The International Cancer Research Partnership (ICRP) is an active network of cancer research funding organizations, sharing information about funded research projects in a common database. Data are publicly available to enable the cancer research community to find potential collaborators and avoid duplication. This study presents an aggregated analysis of projects funded by 120 partner organizations and institutes in 2006-2018, to highlight trends in cancer research funding. Overall, the partners’ funding for cancer research increased from $5.562 billion (bn) US dollars (USD) in 2006 to $8.511bn USD in 2018, an above-inflation increase in funding. Analysis by the main research focus of projects using Common Scientific Outline categories showed that Treatment was the largest investment category in 2018, followed by Early Detection, Diagnosis, and Prognosis; Cancer Biology; Etiology; Control, Survivorship, and Outcomes; and Prevention. Over the 13 years covered by this analysis, research funding into Treatment and Early Detection, Diagnosis, and Prognosis had increased in terms of absolute investment and as a proportion of the portfolio. Research funding in Cancer Biology and Etiology declined as a percentage of the portfolio, and funding for Prevention and Control, Survivorship and Outcomes remained static. In terms of cancer site–specific research, funding for breast cancer and colorectal cancer had increased in absolute terms but declined as a percentage of the portfolio. By contrast, investment for brain cancer, lung cancer, leukemia, melanoma, and pancreatic cancer increased both in absolute terms and as a percentage of the portfolio.

scholarly journals Discrepancies between Canadian cancer research funding and site-specific cancer burden: a spotlight on ten disease sites

2018 ◽  
Vol 25 (5) ◽  
Author(s):  
A. C. Coronado ◽  
C. Finley ◽  
K. Badovinac ◽  
J. Han ◽  
J. Niu ◽  
...  
Keyword(s):  
Cancer Research ◽  
Research Funding ◽  
Information Management System ◽  
Site Specific ◽  
Cancer Burden ◽  
Specific Research ◽  
Research Survey ◽  
Research Investment ◽  
Incidence And Mortality ◽  
Specific Cancer

BackgroundCancer research is essential in evaluating the safety and effectiveness of emerging cancer treatments, which in turn can lead to ground-breaking advancements in cancer care. Given limited research funding, allocating resources in alignment with societal burden is essential. However, evidence shows that such alignment does not typically occur. The objective of the present study was to provide an updated overview of site-specific cancer research investment in Canada and to explore potential discrepancies between the site-specific burden and the level of research investment.MethodsThe 10 cancer sites with the highest mortality in 2015—which included brain, female breast, colorectal, leukemia, lung, non-Hodgkin lymphoma, ovary, pancreas, prostate, and uterus—were selected for the analysis. Information about site-specific research investment and cancer burden (raw incidence and mortality) was obtained from the Canadian Cancer Research Survey and Statistics Canada’s cansim (the Canadian Socio-Economic Information Management System) respectively. The ratio of site-specific research investment to site-specific burden was used as an indicator of overfunding (ratio > 1) or underfunding (ratio < 1).ResultsThe 3 cancer sites with the highest research investments were leukemia, prostate, and breast, which together represented 51.3% of 2015 cancer research funding. Conversely, the 3 cancer sites with the lowest investments were uterus, pancreas, and ovary, which together represented 7.8% of 2015 research funding. Relative to site-specific cancer burden, the lung, uterus, and colorectal sites were consistently the most underfunded.ConclusionsObserved discrepancies between cancer burden and research investment indicate that some cancer sites (such as lung, colorectal, and uterus) seem to be underfunded when site-specific incidence and mortality are taken into consideration.

International research delivers many rewards

Impact ◽  
2020 ◽  
Vol 2020 (6) ◽  
pp. 84-85
Author(s):  
Lucy Annette
Keyword(s):  
Experimental Design ◽  
International Collaboration ◽  
International Research ◽  
Research Funding ◽  
Research Focus ◽  
World Class ◽  
Opening Up

International collaboration in research is not a new concept, but as pressure on research funding increases, project applications for funding must deliver a comprehensive package of well-considered experimental design, impactful research focus and a world-class team. Collaborations with key international leaders in their fields are an excellent way of boosting the credentials of any project, increasing the chances of the group getting funding by opening up their pool of potential funders.

An analysis of cancer research funding in the UK

2003 ◽  
Vol 3 (2) ◽  
pp. 139-143 ◽  
Author(s):  
Liam O'Toole ◽  
Paul Nurse ◽  
George Radda
Keyword(s):  
Cancer Research ◽  
Research Funding ◽  
The Uk

scholarly journals Chikungunya outbreak in Al-Hudaydah, Yemen, 2011: Epidemiological characterization and key lessons learned for early detection and control

2014 ◽  
Vol 4 (3) ◽  
pp. 203 ◽  
Author(s):  
Mamunur Rahman Malik ◽  
Abraham Mnzava ◽  
Emad Mohareb ◽  
Alia Zayed ◽  
Abdulhakeem Al Kohlani ◽  
...  
Keyword(s):  
Early Detection ◽  
Lessons Learned ◽  
And Control ◽  
Epidemiological Characterization

HIEQ LAB: A NOVEL FULL-SCALE FACILITY WITH OCCUPANTS TO INVESTIGATE INTEGRATIVE LIGHTING AND HUMAN PERFORMANCE IN A MULTI-DOMAIN APPROACH

2021 ◽  
Author(s):  
L. Giovannini ◽  
V.R.M. Lo Verso ◽  
F. Favoino ◽  
V. Serra ◽  
A. Pellegrino
Keyword(s):  
Human Performance ◽  
Well Being ◽  
Energy Performance ◽  
Real Space ◽  
Indoor Environmental Quality ◽  
Design Strategies ◽  
Main Research ◽  
Building Components ◽  
Lighting Systems ◽  
And Control

The new HIEQ Lab (Health, well-being and Indoor Environmental Quality Laboratory) is presented. It is a living lab, primarily intended for research on human performance, comfort, and well-being, integrated with the energy performance in a completely controlled real space. Users are involved as active players in controlling and assessing building components and design strategies for health, well-being and IEQ requirements. Experimental activities will be addressed through a multi-domain approach that combines lighting, acoustic, air quality and thermal issues. For what concerns lighting, the laboratory is conceived to study the performance of daylighting and electric lighting systems and control solutions, focusing on the relationship between lighting conditions and human performance, comfort, and well-being. The paper reports the results of a literature review on existing lighting research facilities, and then describes the features of the new HIEQ Lab and its main research objectives, with a focus on lighting and daylighting research opportunities.

Sign in / Sign up

Export Citation Format

Share Document